Alere Inc (NYSE:ALR)
During the Trading Day
| 25.55 |  -0.49 / -1.88% |
Data as of 4:03pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 25.57 |  +0.02 / +0.08% |
Volume: 5.9K |
Latest ALR News | Press Releases
| 1 Reason Alere May Be Headed for a Slowdown May 21 / MotleyFool.com | Alere Beats on Both Top and Bottom Lines May 10 / MotleyFool.com |
| Is Alere's Cash Flow Just For Show? May 17 / MotleyFool.com | Alere Beats Earnings Est, Turns to Profit - Analyst Blog May 10 / Zacks.com |
Today’s Trading
| Previous close | 26.04 |
| Today’s open | 25.93 |
| Day’s range | 25.38 - 25.97 |
| Volume | 708,985 |
| Average volume (3 months) | 669,743 |
| Market cap | $2.1B |
| Dividend yield | -- |
Data as of 4:03pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +22.15% |
| Earnings growth (this year) | -1.98% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +18.11% |
| P/E ratio | NM |
| Price/Sales | 0.53 |
| Price/Book | 1.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TECHTechne Corp | -0.26 | -0.39% |
| NEOGNeogen Corp | +0.09 | +0.16% |
| GHDXGenomic Health Inc | 0.00 | 0.00% |
| VIVOMeridian Bioscience ... | +0.23 | +1.06% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $0.49 |
| Annual revenue (last year) | $2.8B |
| Annual profit (last year) | -$78.2M |
| Net profit margin | -2.77% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Ronald Zwanziger, MBA |
Chief Operating Officer Namal Nawana, MBA |
Corporate headquarters Waltham, Massachusetts |
Forecasts
